Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2015 August;63(4) > Minerva Cardioangiologica 2015 August;63(4):253-74

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

REVIEWS  


Minerva Cardioangiologica 2015 August;63(4):253-74

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

How to define bifurcation lesion complexity and how to successfully perform percutaneous treatment

Grundeken M. J. 1, Kraak R. P. 1, De Winter R. J. 1, Serruys P. W. 2, Wykrzykowska J. J. 1

1 Amsterdam Heart Center, Academic Medical Center, Amsterdam, The Netherlands; 2 International Centre for Circulatory Health, NHLI, Imperial College London, London, UK


PDF  


Historically, percutaneous coronary interventions (PCI) of bifurcation lesions have been associated with a lower procedural success rate, a higher complication rate, and less favorable clinical outcomes, compared to PCI of non-bifurcation lesions. However, percutaneous treatment of coronary bifurcation lesions have been improved over the past decade due to improvements in stent design and the introduction of specific bifurcation stent techniques. Some even argue that PCI of bifurcation lesions should no longer be considered as being complex. However, recent studies have shown that there are still certain bifurcation lesion subtypes which are at higher risk for adverse cardiac events after PCI. Future efforts, including the development of a dedicated bifurcation device, should be focused on this specific high-risk subgroup, including distal left main bifurcations.

top of page

Publication History

Cite this article as

Grundeken MJ, Kraak RP, De Winter RJ, Serruys PW, Wykrzykowska JJ. How to define bifurcation lesion complexity and how to successfully perform percutaneous treatment. Minerva Cardioangiol 2015 August;63(4):253-74. 

Corresponding author e-mail

m.j.grundeken@amc.uva.nl